MARINA BIOTECH INC COM STK (DE)
MRNA
MRNA was delisted on the 1st of February, 2012.
2 hedge funds and large institutions have $16.6K invested in MARINA BIOTECH INC COM STK (DE) in 2024 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 2 → 2 (0)
63% less capital invested
Capital invested by funds: $45K → $16.6K (-$28.4K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BAM
Byrne Asset Management
Kingston,
New Jersey
|
-$8.22K |
MRNA Hedge Fund Activity: Q3 2024 in Review
2 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in MARINA BIOTECH INC COM STK (DE) (MRNA) for Q3 2024, worth a combined $16.6K — down 63% from $45K a quarter earlier.
Fund positioning in MRNA was balanced in Q3 2024: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was Byrne Asset Management, cutting an estimated $8.22K.
- 2 institutional investors held MARINA BIOTECH INC COM STK (DE) (MRNA) as of Q3 2024, unchanged from Q2 2024.
- Funds reported $16.6K of MARINA BIOTECH INC COM STK (DE) stock for Q3 2024, down 63% quarter-over-quarter.
- 0 funds opened new MARINA BIOTECH INC COM STK (DE) positions in Q3 2024 and 0 closed out.
- The largest MARINA BIOTECH INC COM STK (DE) seller in Q3 2024 was Byrne Asset Management, an estimated $8.22K sold.
Based on aggregated 13F filings for Q3 2024.